ONCOSIL MEDICAL
2004 - OncoSilTM was originally developed as BrachySilTM. pSivida grants exclusive worldwide royalty-bearing license agreement with Enigma Therapeutics for the development of BrachySil All preclinical and early phase clinical work conducted under sponsorship of pSivida February 2013 - Enigma Therapeutics was acquired by NeuroDiscovery Ltd June 2013 - NeuroDiscovery Ltd changed its name to OncoSil Medical Ltd and focused on developing OncoSilTM OncoSil Medical Ltd is an ASX-listed Medical Device Biotechnology Company headquartered in Sydney, Australia with global representation
ONCOSIL MEDICAL
Industry:
Medical Device Therapeutics
Address:
North Sydney, New South Wales, Australia
Country:
Australia
Status:
Active
Contact:
+61 2 9223 3344
Email Addresses:
[email protected]
Similar Organizations
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Current Employees Featured
More informations about "OncoSil Medical"
Dr Boreham’s Crucible: Will ditching its baggage help …
1 day ago Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA in early 2025.See details»
OncoSil Medical - Crunchbase Company Profile & Funding
OncoSil Medical Ltd is a Sydney-based medical device company focused on interventional oncology in the pancreas.See details»
OncoSil Medical Limited | European Clinical Trials Information …
The study focuses on patients dealing with locally advanced pancreatic adenocarcinoma, a type of pancreatic cancer. It aims to evaluate the effectiveness of combining a treatment called …See details»
OncoSil Medical’s Strategic Advancements in Cancer Treatment
Nov 13, 2024 OncoSil Medical Limited is set to host an investor webinar to highlight recent milestones and strategic plans in commercializing its innovative cancer treatment device for …See details»
First Patient Enrolled in OncoSil Medical's PANCOSIL …
Dec 5, 2023 OncoSil Medical CEO and managing director Nigel Lange added, "We are excited by news that the first patient has been treated in the PANCOSIL study. The recruitment of patients to this study represents another significant …See details»
OncoSil Medical Ltd: A Comprehensive Company …
Nov 4, 2023 OncoSil Medical is guided by a compelling mission: to enhance the lives of individuals impacted by cancer. The company’s core mission revolves around the selective and targeted intratumoral ...See details»
Revolutionizing Pancreatic Cancer Treatment: A Closer Look at
Dec 1, 2023 The OncoSil™ device, a product of their innovative efforts, promises a localized and targeted approach to pancreatic cancer treatment.See details»
Why OncoSil Medical is calling time on pancreatic …
Nov 29, 2021 At OncoSil Medical, we are working alongside key opinion leaders in field of pancreatic cancer, with the aim to collectively develop our technology and to ultimately provide benefit to people ...See details»
Healthcare Professionals - OncoSil
OncoSil Medical is a global medical device company focused on Interventional Oncology. Our mission is to improve the outcomes for people living with cancer by utilising selective and targeted intratumoral placement of Phosphorous 32 …See details»
Patients | OncoSil
OncoSil™ is a single-use brachytherapy (internal radiation) device used to deliver a pre-determined dose of beta radiation directly into cancerous tissue. OncoSil™ carries the active component radioactive Phosphorous (P-32) microparticles. …See details»
OncoSil™ in Unresectable Locally Advanced Pancreatic ... - ICH GCP
Dec 20, 2016 An 8-weekly review of medical records will be used to monitor possible device or late radiation related adverse events, and oncology treatments/procedures administered for up …See details»
The London Clinic introduces OncoSil treatment for pancreatic …
May 27, 2021 OncoSil medical .president EMEA Nigel Lange. “I am delighted that The London Clinic will be the first institution in the UK to routinely offer patients with unresectable locally …See details»
PowerPoint Presentation
The speaker has no other relevant financial conflicts of interests in OncoSil Medical, Ltd., and provides no product endorsement. This presentation represents a technical overview for …See details»
Revolutionizing Cancer Treatment with Oncosil: A Beacon of Hope
Oct 16, 2023 Oncosil, a groundbreaking medical solution, is leading the way in the fight against pancreatic cancer, a disease that has long presented a significant challenge to the medical …See details»
Oncidium - About Us
Oncidium is now CloudMD. We are a multi-disciplinary, Health & Wellness Company leading the way in reducing occupational absence by delivering solutions that improve the health of …See details»
ONE CARE MEDICAL - NPI 1457682189 - Internal Medicine in …
Jan 20, 2010 Is Organization Subpart? An internist like One Care Medical is a physician who has completed an internal medicine residency and is board-certified or board-eligible in an internist …See details»
Sentara Northern Virginia Medical Center - Wikipedia
Sentara Northern Virginia Medical Center (SNVMC) is a 183-bed, not-for-profit community hospital serving Prince William County and its surrounding communities. Potomac Hospital, an …See details»
First Commercial Pancreas Cancer Treatment With The OncoSil™ …
Apr 20, 2022 Sydney, Australia – 13 April 2022: OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company), a medical device company focused on localised treatments for patients with locally …See details»
SENTARA NORTHERN VIRGINIA MEDICAL CENTER - NPI …
Sep 16, 2006 Sentara Northern Virginia Medical Center is a hospital serving the Woodbridge, Virginia region. The facility is a general acute care hospital. The NPI number of this hospital is …See details»